March/April 2011

Examining new and emerging therapies to meet the unmet needs of patients with asthma.

By 2012, we estimate that more than 3 of every 4 prescriptions will be filled with a generic drug.

This is the first of a 2-part series on the development of the essential health benefit package prescribed under the Patient Protection and Affordable C are Act.

A small proportion of patients with chronic conditions have very high healthcare expenditures, and a trend was observed toward increasing coinsurance requirements.

Efficacy, toxicity, and costs are all important components of formulating an appropriate care pathway for unresectable locoregionally advanced and metastatic NSCLC.

Systems exist that enable storage of parenteral drugs in single-use vials for more than the 6 hours currently permitted, decreasing waste and increasing savings.

A pharmacy benefit that covers both inpatient and outpatient medications would ensure safe, cost-effective care in an integrated, automated way across all healthcare venues.

Previously diagnosed schizophrenia patients have lower inpatient and higher drug costs compared with newly diagnosed patients, possibly indicating better control of their disease.